Embargo Watch

Keeping an eye on how scientific information embargoes affect news coverage

Search Results

PNAS lifts embargo on cancer detection study after reporting by Sunday Times, Daily Mail

leave a comment »

pnas juneThe Proceedings of the National Academy of Sciences (PNAS) lifted the embargo early yesterday on a study of a potential new blood marker for cancer after two newspapers reported on the findings before the scheduled lift time of 3 p.m. Eastern today.

Here’s the top of an email sent to reporters yesterday: Read the rest of this entry »

Written by Ivan Oransky

February 23, 2015 at 6:17 pm

Posted in Uncategorized

Colon cancer study embargo lifted early after “gremlin in the machinery” leads to break

leave a comment »

eortcThe embargo on a colon cancer presentation at a Barcelona conference was lifted early Thursday after inadvertent breaks.

On Thursday morning, European Organization for Research and Treatment of Cancer (EORTC) media consultant Emma Mason sent the following message to her press list: Read the rest of this entry »

Written by Ivan Oransky

November 23, 2014 at 3:55 pm

Posted in Uncategorized

New York Times, researcher won’t face sanctions for breast cancer screening embargo break

with one comment

nytLast month, as Embargo Watch reported, a New York Times op-ed by Dartmouth’s Gil Welch broke the embargo on a study Welch and a colleague were publishing the next day in JAMA Internal Medicine.

At the time, I wondered whether Welch and the Times would face sanctions. Now we have the answer.

JAMA’s editor-in-chief, Howard Bauchner, tells Embargo Watch: Read the rest of this entry »

Written by Ivan Oransky

January 16, 2014 at 9:45 am

Posted in Uncategorized

Author breaks JAMA journal embargo on his own study with New York Times cancer screening op-ed

leave a comment »

Gil Welch, via Dartmouth

Gil Welch, via Dartmouth

Gil Welch, who has scrutinized cancer screening in a number of venues, has two-thirds of a publishing hat trick this week: An op-ed in the New York Times, and an article in JAMA Internal Medicine.

Trouble is, the op-ed broke the embargo on the JAMA Internal Medicine paper.

From the JAMA press office today: Read the rest of this entry »

Written by Ivan Oransky

December 30, 2013 at 12:17 pm

Posted in Uncategorized

European Cancer Congress lifts all embargoes after abstracts fall into financial analysts’ hands

with one comment

logo_eccoThe European Cancer Congress, the conference of the European CanCer Organisation (ECCO), sent this email to its press list a little while ago:

Due to circumstances beyond our control we are lifting embargoes on all European Cancer Congress press releases as of now. The abstracts are all online now, including late-breaking abstracts. They can be found here:

http://eccamsterdam2013.ecco-org.eu/Scientific-Programme/Searchable-Programme.aspx#anchorScpr

Therefore, for the remainder of the Congress we will email out the rest of our press releases either on the day of presentation to the congress or the press conference (whichever is earlier) and they will be for immediate release.

What happened? ECCO tells Embargo Watch: Read the rest of this entry »

Written by Ivan Oransky

September 27, 2013 at 4:33 pm

Posted in Uncategorized

Harvard hospital apologizes for promoting “weak” data on aspartame, cancer

leave a comment »

Earlier this week, Brigham & Women’s Hospital sent out a press released titled, “The truth isn’t sweet when it comes to artificial sweeteners.” It’s the kind of release that was likely to grab lots of reporters’ attention.

But today, the hospital did something familiar during political season: They walked back that press release, apologizing for having sent it out.

Apparently, this was skeptical journalism in action. As NBC News’ Robert Bazell writes: Read the rest of this entry »

Written by Ivan Oransky

October 24, 2012 at 4:16 pm

Posted in Uncategorized

Confusion as JNCI yanks press release on embargoed breast density-cancer study after authors see error

leave a comment »

An unusual note went out to reporters on the Journal of the National Cancer Institute (JNCI) press list yesterday:

Please disregard this MTM, which was sent out on Friday June 29, 2012.  The data in the study changed so we are no longer putting out a press release for the study.

The original release was headlined:

Percent Density May Be As Strong a Risk Factor as Variation in Breast Density for Breast Cancer

MTM stands for “memo to the media.” What wasn’t clear was whether the new notice meant the release was being pulled back, or the study itself, but the JNCI press office said it was just the release.

But the Mayo Clinic’s Celine Vachon told Embargo Watch: Read the rest of this entry »

Written by Ivan Oransky

July 3, 2012 at 4:15 pm

Posted in Uncategorized

ASCO lifts embargo early on study of breast cancer drug T-DM1 after break

leave a comment »

In what has become an annual ritual, the American Society of Clinical Oncology (ASCO) meeting now underway in Chicago has been the subject of an embargo break. From a message sent by ASCO last night to reporters: Read the rest of this entry »

Written by Ivan Oransky

June 3, 2012 at 9:29 am

Posted in Uncategorized

USPSTF takes another tack on announcing screening guidelines, this time on cervical cancer

leave a comment »

Here’s an announcement from this week that marks an unusual move by a government-backed group that offers guidelines on various tests:

The U.S. Preventive Services Task Force (USPSTF) will publish its final recommendations on screening for cervical cancer in the Annals of Internal Medicine and on their website on Wednesday, March 14th.

This announcement is currently public information.

The announcement then details how reporters can obtain embargoed copies of a USPSTF press release on the new guidelines, and the recommendations themselves.

I won’t be breaking the embargo by saying that this involves — wait for it — women. And the USPSTF published a draft version of the guidelines for public comment in October.

That move, however Read the rest of this entry »

Written by Ivan Oransky

March 9, 2012 at 12:17 pm

Posted in Uncategorized

AACR lifts diet-breast cancer study embargo early after MSNBC break

leave a comment »

The American Association for Cancer Research (AACR) lifted the embargo early yesterday on a study of diet and breast cancer after MSNBC ran a story ahead of schedule. From the AACR press office:

The embargo on the Dr. Michelle Harvie study, “Intermittent, Low-Carbohydrate Diets More Successful Than Standard Dieting, Present Possible Intervention for Breast Cancer Prevention,” originally scheduled for 5 p.m. CT today has been lifted due to an embargo break by MSNBC this morning. All reporters are free to release their stories at this time.

Dr. Harvie is scheduled to present this study in a poster presentation at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium today at 5 p.m. CT.

I contacted the AACR to ask whether MSNBC would face any sanctions, but haven’t heard back.

One wonders if they will face the kind of sanctions another news outlet faced when they broke a Microsoft embargo earlier this week. Read the rest of this entry »

Written by Ivan Oransky

December 9, 2011 at 9:30 am

Posted in Uncategorized

Follow

Get every new post delivered to your Inbox.

Join 24,707 other followers